Table 1.
Author | Study site | Year conducted | Study design | Participants | Age | Sex (M:F) | All co-infection | Salmonella spp. with typhoid | Salmonella spp. with non-typhoid | All malaria cases | Malaria without typhoid | Typhoid without malaria | Test for malaria | Test for typhoid |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abah et al. (2019)75 | Nigeria | 2016 | Cross-sectional study | 500 Febrile patients | 1–60 years | 244:256 | 115 | 115 | 0 | 278 | 163 | 85 | Microscopy | Widal test |
Achonduh-Atijegbe et al. (2016)35 | Cameroon | 2014 | Cross-sectional study | 315 Febrile children (6 months–15 years) | 5.8 years (± 3.8) | 157:158 | 14 | 14 | 193 | 179 |
S. typhi and S. paratyphi (14) |
Microscopy, RDT, PCR | Rapid diagnostic test | |
Afoakwah et al. (2011)76 | Ghana | NS | Cross-sectional study | 129 Patients clinically diagnosed as having malaria | 5–83 years | 0.58125 | 6 | 6 | 24 | 18 | 26 | RDT | Widal test | |
Agwu et al. (2009)36 | Nigeria | 2003–2004 | Cross-sectional study | 560 Febrile known HIV/AIDS (239 male and 321 female) patients | < 10 years (30), 11–20 (86), 21–30 (252), 31–40 (183), 41–50 (7), > 50 (2) | 239:321 | 117 | 117 | 418 | P. falciparum (301) | S. typhi (73) | Microscopy | Widal test | |
Akinyemi et al. (2007)37 | Nigeria | 2004–2005 | Cross-sectional study | 235 Febrile patients | 0–5 years (29), 6–15 (31), 16–30 (22), 31–45 (15), > 46 (10) | 16 | 16 | 0 | 107 | 91 | 26 | Microscopy | Blood culture | |
Akinyemi et al. (2015)38 | Nigeria | 2010–2011 | Cross-sectional study | 135 Febrile patients | NS | NS | 4 | 4 | 9 | 5 |
S. typhi (22), S. paratyphi (7) |
Microscopy | Blood culture | |
Alhassan et al. (2012)77 | Nigeria | NS | Cross-sectional study | 300 Febrile patients | 0 to > 60 years | 143:157 | 4 | 4 | 51 | 47 | NS | Microscopy | Blood culture | |
Ali et al. (2020)39 | Tanzania | 2015 | Cross-sectional study | 149 Febrile patients | Mean, 22 years; range, 1–70 | 62:87 | 1 | 1 | 7 | 6 | 0 | Molecular method | Molecular method | |
Ammah et al. (1999)40 | Cameroon | 1997–1998 | Cross-sectional study | 200 Febrile patients | Mean, 28 years (± 20.1); range, 4–75 | 88:112 | 103 | 38 | 65 | 115 | 12 |
S. typhi (10), S. paratyphi (5), S. typhimurium (4) |
Microscopy | Widal test |
Anabire et al. (2018)41 | Ghana | 2015 | Cross-sectional study | 150 Febrile children | Median, 3 years (IQR, 2–8 years) | 77:73 | 9 | 9 | 85 | 76; median age, 4.0 (2.0–8.0); anemia (55/76); thrombocytopenia (47/76); leukopenia (2/76); CBC | S. typhi (20): median age, 6.5 (3.0–11.0); anemia (12/20); thrombocytopenia (2/20); leukopenia (0); CBC | Microscopy, RDT | Widal test | |
Anjorin et al. (2020)42 | Nigeria | 2016–2018 | Cross-sectional study | 182 Pregnant women having influenza-like illness | Mean, 29.3 years; range, 18–45 | 34 | 34 | 34 | NS | Rapid diagnostic test | ||||
Aung et al. (2018)78 | Myanmar | 2016–2017 | Prospective study | 20 Patients with P. falciparum | > 16 years | 19:01 | 1 | 1 | 20 | 19 | NS | Microscopy, RDT | Blood culture | |
Bassat et al. (2009)79 | Mozambique | 2003–2007 | Retrospective study | 1404 Children with severe malaria | < 5 years | NS | 12 | 0 | 12 | 1404 | 1382 | NS | Microscopy | Blood culture |
Berkley et al. (1999)80 | Kenya | 1993–1996 | Prospective study | 783 Children with severe malaria | NS | 396:387 | 6 | 0 | 6 | 783 | 777 | NS | Microscopy | Blood culture |
Bhalla et al. (2019)43 | India | 2018 | Cross-sectional study | 607 Patients with dengue, malaria, leptospirosis, typhoid, and rickettsia diseases | NS | Positive cases (male, 383:224) | 1 | 1 | 372 | 371 | 45 | Microscopy | Widal test | |
Bhattacharya et al. (2013)81 | India | 2004 | Prospective study | 3371 Febrile patients | Mean, 24.7 years | 1730 :1641 | 2 | 2 | 0 | 93 | 91 | 159 | Microscopy | Blood culture |
Biggs et al. (2014)44 | Tanzania | 2006–2007 | Cross-sectional study | 3639 Febrile children | Median 1.57 years (0.2–13.0) | 1970: 1669 | 53 | 53 | 2195 | 2142 | S. typhi (11), non-typhoidal Salmonella (109) | Microscopy, RDT | Blood culture | |
Birhanie et al. (2014)45 | Ethiopia | 2013 |
Cross-sectional Study |
200 Febrile patients | 24.24 ± 13.4, range 2 to > 46 | 120:80 | 13 | 13 | 73 | 60 | 25 | Microscopy | Widal test | |
Brent et al. (2006)29 | Kenya | 1998–2002 | Prospective study | 166 Non-typhoidal Salmonella | Median 15 months (8–27) | 54 | 0 | 54 | 54 | 0 | 112 | ELISA | Blood culture | |
Bronzan et al. (2007)30 | Malawi | 1996–2005 | Cross-sectional study | 1388 Severe malaria with bacteriamia | Children > 6 months | 37 | 37 | 1388 | 1351 | NS | Microscopy | Blood culture | ||
Chipwaza et al. (2015)46 | Tanzania | 2013 | Cross-sectional study | 370 Febrile patients | 2–13 years | 189:181 | 13 | 13 | 98 | 85 | 38 | Microscopy | Widal test | |
Chukwuma et al. (2014)82 | Nigeria | 2012–2013 | Cross-sectional study | 350 Pregnant women | 5 | 5 | 0 | 10 | 5 | 1 | Microscopy | Stool culture | ||
Edet et al. (2016)83 | Nigeria | 2014–2015 | Cross-sectional study | 100 Febrile patients | 10–80 years | 43:57:00 | 11 | 11 | 0 | 41 | 30 | 0 | Microscopy | Blood culture |
Ekesiobi et al. (2017)84 | Nigeria | NS | Cross-sectional study | 256 Febrile patients | 1 to > 35 years | 128:128 | 29 | 25 | 4 | 202 | 173 | 9 | Microscopy | Stool culture |
Enabulele et al. (2016)47 | Nigeria | NS | Cross-sectional study | 271 Febrile patients | > 18 years | NS | 5 | 5 | 193 | 188 | 24 | Microscopy | Widal test | |
Evans et al. (2004)85 | Ghana | NS | Cross-sectional study | 23 Children with severe malaria | NS | NS | 10 | 0 | 10 | 23 | 13 | 19 | Microscopy | Blood culture |
Eze et al. (2011)48 | Nigeria | NS | Cross-sectional study | 25 Malaria cases | NS | NS | 3 | 3 | 25 | 22 | 0 | NS |
Widal tes t |
|
Falay et al. (2016)49 | Democratic Republic of the Congo | 2012 | Cross-sectional study | 16 S. typhi positive, 107 Non-typhoidal Salmonella | S. typhi positive (median 96 (48–123) months), non-typhoidal Salmonella (median 24 (12–36)) | S. typhi positive (7:9), non-typhoidal Salmonella (63:45) | 63 | 5 | 58 | 0 | S. typhi positive (11), non-typhoidal Salmonella (59) | Microscopy, RDT | Blood culture | |
Graham et al. (2000)17 | Malawi | 1996–1998 | Cross-sectional study | 219 Non-typhoidal Salmonella | > 6 months | NS | 82 | 82 | 0 | 144 | Microscopy | Blood culture | ||
Ibrahim et al. (2019)86 | Burkina Faso | 2014 | Cross-sectional study | 283 Malaria cases | Median 18 (0–85 years) | 140:143 | 91 | 91 | 0 | 283 | 192 | NS | Microscopy | Widal test |
Igbeneghu et al. (2009)50 | Nigeria | NS | Cross-sectional study | 258 Febrile Patients | NS | NS | 1 | 1 | 161 | 160 | 1 | Microscopy | Blood culture | |
Igharo et al. (2012)51 | Nigeria | NS | Cross-sectional study | 234 Febrile patients | NS | 113:121 | 43 | 43 | 88 | 45 | 130 | Microscopy | Widal test | |
Jalani et al. (2019)52 | Pakistan | 2017 | Cross-sectional study | 144 Febrile patients | 1–10 (75), 11–20 (35), > 20 (34) | 74:70 | 9 | 9 | 20 | 11 | 86 | Microscopy | Widal test | |
Kargbo et al. (2014)87 | Sierra Leone | 2013–2014 | Cross-sectional study | 11,069 Febrile patients | 5–70 years |
5245: 5824 |
2101 | 2101 | 0 | 8849 | 6748 | 554 | Microscopy | Widal test |
Katiyar et al. (2020)88 | India | 2018 | Cross-sectional study | 780 Malaria cases | 0–80 years | 425:355 | 122 | 122 | 0 | 780 | 658 | NS | Microscopy, RDT | Widal test |
Krumkamp et al. (2016)53 | Ghana | 2007–2012 | Cross-sectional study | 6746 Febrile patients | < 15 years | 33 | 33 | 2563 | 2530 | Non-typhoidal Salmonella (160), S. typhi (93) | Microscopy | Blood culture | ||
Mabey et al. (1987)31 | Gambia | 1979–1984 | Cross-sectional study | 116 Patients with typhoidal/non-typhoidal Samonella | 35 | 5 | 30 | 35 | NS | 81 | Microscopy | Blood culture | ||
Maltha el al. (2014)54 | Burkina Faso | 2012–2013 | Cross-sectional study | 711 Severe malaria | Median 19 (10–36) | 393:318 | 33 | 12 | 21 | 711 | 678 | 0 | Microscopy, RDT | Blood culture |
Mbuh et al. (2003)89 | Nigeria | 1996 | Cross-sectional study | 218 Febrile patients | 2–59 years | 118:100 | 1 | 1 | 0 | 60 | 59 | 0 | Microscopy | Blood culture |
Mike et al. (2017)90 | Nigeria | 2015 | Retrospective study | 627 Febrile patients | 1–75 years | 375:252 | 136 | 136 | 0 | 233 | 97 | 49 | Microscopy | Widal test |
Mohammed et al. (2020)91 | Nigeria | 2020 | Cross-sectional study | 429 Pregnant women | 21–30 years | 429 | 12 | 12 | 0 | 123 | 111 | 33 | Microscopy, RDT | Rapid diagnostic test |
Mourembou et al. (2016)55 | Gabon | NS | Cross-sectional study | 410 Febrile patients | < 16 years | 212:198 | 3 | 323 | 320 | 0 | Molecular method | Molecular method | ||
Mtove et al. (2010)20 | Tanzania | 2008–2009 | Cross-sectional study | 156 Children with pathogenic bacteriamia | 2 months to 14 years | 34 | 3 | 31 | 0 | S. typhi (11), non-S. Typhi (14) | Microscopy, RDT | Blood culture | ||
Ndip et al. (2015)92 | Cameroon | 2010 | Cross-sectional study | 206 Febrile patients | 4–80 years | 12 | 12 | 0 | 186 | 174 | 14 | Microscopy | Stool culture | |
Nielsen et al. (2015)56 | Ghana | 2007–2011 | Cross-sectional study | 771 Malaria cases | < 15 years | 1049:866 | 21 | 21 | 771 | 750 | 0 | Microscopy | Blood culture | |
Njolle et al. (2020)93 | Cameroon | 2015 | Cross-sectional study | 160 Febrile patients | 18 months–60 years | 81:79 | 12 | 9 | 3 | 31 | 19 | Typhoid (55), non-typhoidal Salmonella (24) | Microscopy | Stool culture |
Nwabueze et al. (2013)94 | Nigeria | NS | Cross-sectional study | 700 Pregnant women | NS | NS | 236 | 236 | 0 | 512 | 276 | NS | Microscopy | Widal test |
Nwuzo et al. (2009)57 | Nigeria | 2007 | Cross-sectional study | 250 Febrile patients | 0–70 years | 123:127 | 14 | 14 | 33 | 19 | S. typhi (39) | RDT | Blood culture | |
Nyein et al. (2016)58 | Myanmar | 2014–2015 | Cross-sectional study | 67 Adults with P. falciparum | Adults | NS | 4 | 3 | 1 | 67 | 63 | 0 | Microscopy, RDT | Blood culture |
Odikamnoro et al. (2018)59 | Nigeria | NS | Cross-sectional study | 350 Febrile patients | All age groups | 164:186 | 127 | 127 | 190 | 63 | 46 | Microscopy | Widal test | |
Ohanu et al. (2003)95 | Nigeria | 1997–1998 | Cross-sectional study | 270 Febrile patients | 15–59 years | 130:140 | 16 | 16 | 0 | 60 | 44 | 22 | Microscopy | Blood and stool culture |
Omoya et al. (2017)96 | Nigeria | 2015 | Cross-sectional study | 170 Pregnant women | 16–45 years | 170 | 79 | 79 | 0 | 112 | 33 | 35 | Microscopy | Widal test |
Onyido et al. (2014)97 | Nigeria | 2012 | Cross-sectional study | 200 Healthy individuals | 1–80 years | 52:148 | 10 | 10 | 0 | 50 | 40 | 11 | Microscopy | Widal test |
Orok et al. (2016)98 | Nigeria | 2015 | Cross-sectional study | 250 Febrile patients | 1–75 years | 113:137 | 2 | 2 | 0 | 202 | 200 | NS | Microscopy | Blood culture |
Oshiokhayamhe et al. (2021)99 | Nigeria | NS | Cross-sectional study | 200 Students | 18–30 years | 100:100 | 5 | 5 | 0 | 10 | 5 | 25 | Microscopy | Widal test |
Oundo et al. (2002)60 | Kenya | 1997–2001 | Cross-sectional study | 9147 Children with severe malaria | Mean 22.28 months (25.3) | 101 | 101 | 9248 | 9147 | Non-typhoidal Salmonella (352) | Microscopy | Blood culture | ||
Ozumba et al. (2020)100 | Nigeria | 2015 | Cross-sectional study | 200 Pregnant women | < 20 to 60 years | 200 | 8 | 8 | 0 | 16 | 8 | 78 | Microscopy | Widal test |
Pam et al. (2015)101 | Nigeria | 2015 | Cross-sectional study | 250 Pregnant women | < 20 to 60 years | 250 | 9 | 9 | 0 | 16 | 7 | 68 | RDT | Widal test |
Pam et al. (2018)61 | Nigeria | 2015 | Cross-sectional study | 200 Pregnant women | < 20 (6), 21–30 (110), 31–40 (72), 41–50 (10), 51–60 (2) | All were females | 9 | 9 | 25 | 16 | 86 | Microscopy, RDT | Widal test | |
Park et al. (2016)62 | Burkina Faso, Ethiopia, Ghana, Guinea-Bissau, Kenya, Madagascar, Senegal, South Africa, Sudan, and Tanzania | 2010–2014 | Cross-sectional study | 497 Febrile patients | All age groups | NS | 24 | 9 | 15 | 0 | 473 | Microscopy, RDT | Blood culture | |
Phu et al. (2020)63 | Vietnam | 1991–2003 | Cross-sectional study | 845 Adult patients admitted with severe falciparum malaria | > 14 years | NS | 4 | 3 | 1 | 840 | 836, mean age 31 years, range 15–79 years, median parasite count 81,766/μL (12,811 to 316,512/μL) | 0 | Microscopy | Blood culture |
Popoola et al. (2019)64 | Nigeria | 2017 | Cross-sectional study | 682 Febrile patients | < 1 (7), 1–5 (217), 6–12 (189), 13–17 (61), 18–59 (198), ≥ 60 (10) | 332:350 | 7 | 6 | 1 | 171 | 164 | S. typhi (21), non-typhoidal Salmonella (5) | Microscopy | Molecular method |
Qureshi et al. (2019)65 | Pakistan | 2012–2013 | Cross-sectional study | 1889 Febrile patients | All age groups | Infected cases 164:147 | 11 | 11 | 128 | 117 age 1–12 (67), 13–60 (50) | 183, age 1–12 (110), 13–60 (73) | Microscopy | Rapid diagnostic test | |
Raja et al. (2016)66 | India | 2013–2014 | Cross-sectional study | 100 Febrile patients | NS | NS | 2 | 2 | 10 | 8 | 6 | Microscopy, RDT | Blood culture | |
Ramya et al. (2017)67 | India | 2010–2012 | Cross-sectional study | 824 Malaria, typhoid, dengue cases | NS | NS | 55 | 55 | NS | NS | RDT | Widal test | ||
Sajid et al. (2017)102 | Pakistan | NS | Cross-sectional study | 300 Febrile patients | 1 to > 46 years | 150:150 | 21 | 21 | 65 | 44 | 16 | Microscopy | Widal test | |
Sale et al. (2020)103 | Nigeria | NS | Cross-sectional study | 200 Febrile patients | ≤ 10 to > 30 years | 96:104 | 45 | 45 | 0 | 111 | 66 | 33 | Microscopy, RDT | Widal test |
Samatha et al. (2015)68 | India | 2014–2015 | Cross-sectional study | 582 Febrile patients | NS | NS | 4 | 4 | 306 | 302 | Widal test 132, culture 7 | Microscopy | Blood culture | |
Sandlund et al. (2012)69 | Sweden | 1995–2009 | Cross-sectional study | 755 Malaria patients | Mean 33.6 (15.2 years), range 1–79 years (13.68 years), range 18–77 years | 01:01.0 | 4 | 4 | 755 | 751 | 0 |
Microscopy, RDT, molecular Method |
Blood culture | |
Shaikh et al. (2018)70 | Pakistan | 2017–2018 | Cross-sectional study | 985 Febrile patients | Malaria positive: mean 38.63 | Malaria positive: 209:181 | 52 | 52 | 442 | 390 | 250 | NS | Widal test | |
Sharma et al. (2016)104 | India | 2014–2016 | Cross-sectional study | 3010 Febrile patients | Children and adults | 2260:750 | 48 | 48 | 0 | 210 | 162 | 12 | Microscopy, RDT | Blood culture |
Singh et al. (2014)71 | India | 2013 | Cross-sectional study | 1141 Febrile patients | ≥ 12 years | 618:523 | 1 | 1 | 147 | 146 | 92 | Microscopy, RDT | Blood culture | |
Snehanshu et al. (2014)105 | India | 2012–2013 | Cross-sectional study | 200 Febrile patients | 0 to > 60 years | 88:112 | 5 | 5 | 0 | 36 | 31 | NS | Microscopy | Blood culture |
Sur et al. (2006)106 | India | 2004 | Prospective study | 3371 Febrile patients | 0 to > 70 years | NS | 3 | 3 | 0 | 93 | 90 | 92 | Microscopy | Blood culture |
Tabu et al. (2012)72 | Kenya | 2006–2009 | Cross-sectional study | 3578 Febrile (60 non-typhoidal Salmonella investigated for malaria) | NS | NS | 12 | 12 | NS | NS | Non-typhoidal Salmonella (48) | Microscopy | Blood culture | |
Tchuandom et al. (2018)73 | Cameroon | 2016–2017 | Cross-sectional study | 961 Febrile patients | ≤ 15 years, mean 7.1 (2.9 years) | 495:466 | 6 | 6 | 396 | 390 | 22 | RDT | RDT | |
Ukaegbu et al. (2014)107 | Nigeria | NS | Cross-sectional study | 300 Febrile patients | 0 to > 60 years | 117:183 | 9 | 9 | 0 | 162 | 153 | NS | Microscopy | Stool culture |
Vats et al. (2018)108 | India | NS | Cross-sectional study | 300 Febrile patients | 1–60 years | 206:94 | 3 | 3 | 0 | 31 | 28 | 9 | Microscopy | Blood culture |
Verma et al. (2014)74 | India | 2012 | Cross-sectional study | 800 Febrile patients | NS | NS | 9 | 9 | NS | NS | NS | Microscopy, RDT | Blood culture | |
Walsh et al. (2000)27 | Malawi | 1996–1997 | Cross-sectional study | 128 Non-typhoidal Salmonella | 0–13 years | NS | 32 | 0 | 32 | 32 | NS | 96 | Microscopy | Blood culture |
Were et al. (2011)28 | Kenya | 2004–2006 | Cross-sectional study | 585 Children with P. falciparum | 1–36 months | 295:290 | 24 | 0 | 24 | 585 | 561 | NS | Microscopy | Blood culture |
ELISA enzyme-linked immunosorbent assay, NS not specified, RDT rapid diagnostic test.